Nanotechnology in Medical Research

F M Mansfeld, T P Davis, M Kavallaris

Research output: Chapter in Book/Report/Conference proceedingChapter (Book)Researchpeer-review

Abstract

This chapter discusses how nanotechnology already has or is about to revolutionize different aspects of medical and clinical research, with a focus on the diagnosis and monitoring of disease and delivery of therapeutics to treat disease. At this stage, the discipline that has benefited most from advances in nanotechnology is clinical diagnostic imaging, and nanoparticulate contrast agents are already used routinely or are currently under investigation in clinical trials. Drug delivery systems are not far behind, however, and in addition to several FDA-approved nanoformulations, many more formulations which reduce off-target toxicity or increase accumulation of a drug at a specific target site or both, are being explored. In the endeavor to improve public health and health management, a big leap in the realization has been that with the aid of nanotechnology, diagnosis and treatment are not necessarily separate events. They can now be combined through the use of multimodal nanoparticles materials, incorporating one or more reporters as well as the capability to deliver therapeutics. Considering the rapid progress in precise manufacture and characterization of nanoparticle systems and the interaction with their environment, we expect clinical translation of the exciting research in the nanomedical space, to increase in the near future.

Original languageEnglish
Title of host publicationMicro- and Nanotechnology in Vaccine Development
Subtitle of host publicationA volume in Micro and Nano Technologies
EditorsMariusz Skwarczynski, Istvan Toth
Place of PublicationOxford UK
PublisherElsevier
Pages21-45
Number of pages25
ISBN (Print)9780323399814
DOIs
Publication statusPublished - 2017

Keywords

  • Biosensors
  • Drug delivery
  • Medical imaging
  • Multimodal nanoparticles
  • Nanotechnology
  • Theranostics

Cite this

Mansfeld, F. M., Davis, T. P., & Kavallaris, M. (2017). Nanotechnology in Medical Research. In M. Skwarczynski, & I. Toth (Eds.), Micro- and Nanotechnology in Vaccine Development: A volume in Micro and Nano Technologies (pp. 21-45). Oxford UK: Elsevier. https://doi.org/10.1016/B978-0-323-39981-4.00002-6
Mansfeld, F M ; Davis, T P ; Kavallaris, M. / Nanotechnology in Medical Research. Micro- and Nanotechnology in Vaccine Development: A volume in Micro and Nano Technologies. editor / Mariusz Skwarczynski ; Istvan Toth. Oxford UK : Elsevier, 2017. pp. 21-45
@inbook{07f4e67e4217484ba30dbe86c480a65c,
title = "Nanotechnology in Medical Research",
abstract = "This chapter discusses how nanotechnology already has or is about to revolutionize different aspects of medical and clinical research, with a focus on the diagnosis and monitoring of disease and delivery of therapeutics to treat disease. At this stage, the discipline that has benefited most from advances in nanotechnology is clinical diagnostic imaging, and nanoparticulate contrast agents are already used routinely or are currently under investigation in clinical trials. Drug delivery systems are not far behind, however, and in addition to several FDA-approved nanoformulations, many more formulations which reduce off-target toxicity or increase accumulation of a drug at a specific target site or both, are being explored. In the endeavor to improve public health and health management, a big leap in the realization has been that with the aid of nanotechnology, diagnosis and treatment are not necessarily separate events. They can now be combined through the use of multimodal nanoparticles materials, incorporating one or more reporters as well as the capability to deliver therapeutics. Considering the rapid progress in precise manufacture and characterization of nanoparticle systems and the interaction with their environment, we expect clinical translation of the exciting research in the nanomedical space, to increase in the near future.",
keywords = "Biosensors, Drug delivery, Medical imaging, Multimodal nanoparticles, Nanotechnology, Theranostics",
author = "Mansfeld, {F M} and Davis, {T P} and M Kavallaris",
year = "2017",
doi = "10.1016/B978-0-323-39981-4.00002-6",
language = "English",
isbn = "9780323399814",
pages = "21--45",
editor = "Mariusz Skwarczynski and Istvan Toth",
booktitle = "Micro- and Nanotechnology in Vaccine Development",
publisher = "Elsevier",
address = "Netherlands",

}

Mansfeld, FM, Davis, TP & Kavallaris, M 2017, Nanotechnology in Medical Research. in M Skwarczynski & I Toth (eds), Micro- and Nanotechnology in Vaccine Development: A volume in Micro and Nano Technologies. Elsevier, Oxford UK, pp. 21-45. https://doi.org/10.1016/B978-0-323-39981-4.00002-6

Nanotechnology in Medical Research. / Mansfeld, F M; Davis, T P; Kavallaris, M.

Micro- and Nanotechnology in Vaccine Development: A volume in Micro and Nano Technologies. ed. / Mariusz Skwarczynski; Istvan Toth. Oxford UK : Elsevier, 2017. p. 21-45.

Research output: Chapter in Book/Report/Conference proceedingChapter (Book)Researchpeer-review

TY - CHAP

T1 - Nanotechnology in Medical Research

AU - Mansfeld, F M

AU - Davis, T P

AU - Kavallaris, M

PY - 2017

Y1 - 2017

N2 - This chapter discusses how nanotechnology already has or is about to revolutionize different aspects of medical and clinical research, with a focus on the diagnosis and monitoring of disease and delivery of therapeutics to treat disease. At this stage, the discipline that has benefited most from advances in nanotechnology is clinical diagnostic imaging, and nanoparticulate contrast agents are already used routinely or are currently under investigation in clinical trials. Drug delivery systems are not far behind, however, and in addition to several FDA-approved nanoformulations, many more formulations which reduce off-target toxicity or increase accumulation of a drug at a specific target site or both, are being explored. In the endeavor to improve public health and health management, a big leap in the realization has been that with the aid of nanotechnology, diagnosis and treatment are not necessarily separate events. They can now be combined through the use of multimodal nanoparticles materials, incorporating one or more reporters as well as the capability to deliver therapeutics. Considering the rapid progress in precise manufacture and characterization of nanoparticle systems and the interaction with their environment, we expect clinical translation of the exciting research in the nanomedical space, to increase in the near future.

AB - This chapter discusses how nanotechnology already has or is about to revolutionize different aspects of medical and clinical research, with a focus on the diagnosis and monitoring of disease and delivery of therapeutics to treat disease. At this stage, the discipline that has benefited most from advances in nanotechnology is clinical diagnostic imaging, and nanoparticulate contrast agents are already used routinely or are currently under investigation in clinical trials. Drug delivery systems are not far behind, however, and in addition to several FDA-approved nanoformulations, many more formulations which reduce off-target toxicity or increase accumulation of a drug at a specific target site or both, are being explored. In the endeavor to improve public health and health management, a big leap in the realization has been that with the aid of nanotechnology, diagnosis and treatment are not necessarily separate events. They can now be combined through the use of multimodal nanoparticles materials, incorporating one or more reporters as well as the capability to deliver therapeutics. Considering the rapid progress in precise manufacture and characterization of nanoparticle systems and the interaction with their environment, we expect clinical translation of the exciting research in the nanomedical space, to increase in the near future.

KW - Biosensors

KW - Drug delivery

KW - Medical imaging

KW - Multimodal nanoparticles

KW - Nanotechnology

KW - Theranostics

UR - http://www.scopus.com/inward/record.url?scp=85010383586&partnerID=8YFLogxK

U2 - 10.1016/B978-0-323-39981-4.00002-6

DO - 10.1016/B978-0-323-39981-4.00002-6

M3 - Chapter (Book)

SN - 9780323399814

SP - 21

EP - 45

BT - Micro- and Nanotechnology in Vaccine Development

A2 - Skwarczynski, Mariusz

A2 - Toth, Istvan

PB - Elsevier

CY - Oxford UK

ER -

Mansfeld FM, Davis TP, Kavallaris M. Nanotechnology in Medical Research. In Skwarczynski M, Toth I, editors, Micro- and Nanotechnology in Vaccine Development: A volume in Micro and Nano Technologies. Oxford UK: Elsevier. 2017. p. 21-45 https://doi.org/10.1016/B978-0-323-39981-4.00002-6